The number of anti-vaccine bills filed in Texas has risen, yet many Texans support vaccine policy. Fellow Kirstin R.W. Matthews and nonresident scholar Rekha Lakshmanan examine the stakes of legislative engagement in public health initiatives and provide a call to action for Texans to embrace public health as an act of freedom.
Will OPEC+ begin to reverse large production cuts at its June 1 meeting? In large part, it will depend on whose oil market outlook is closest to the mark, writes Mark Finley, fellow in energy and global oil. He examines several forecasts and outlines the issues in a new commentary.
Mark Finley explains the cost-benefit analysis behind the Saudi government's recent move to pause plans to increase spare oil production capacity — and why spare capacity still equates to power in the oil market.
“Nearly one billion travelers pass through U.S. airports each year,” writes Alicia L. Johnson, civic science postdoctoral associate. In a new commentary, she outlines how the CDC’s genomic surveillance program, which monitors airport wastewater for traces of infectious disease, must balance public health and privacy concerns.
When the OPEC+ group met last week and agreed to extend production cuts through the first quarter of 2024, the market was unimpressed. Fellow in Energy and Global Oil, Mark Finley, outlines the meeting’s outcomes and discusses why the recent agreement “could augur a year of difficult meetings ahead” in a new commentary.
The work of Katalin Karikó, 2023 Nobel Prize in Medicine recipient, laid a foundation for the development of COVID-19 mRNA vaccines that saved close to 20 million lives worldwide. But her discoveries almost did not happen, writes Alicia L. Johnson, a civic science postdoctoral associate at the Baker Institute Center for Health and Biosciences. Karikó’s story highlights the vital importance of supporting women in STEM.